A PRINTABLE AGENDA IS AVAILABLE. Archive (Video and Slides) of selected previous year talks is available (last year’s agenda).
Companion Diagnostics Forum 2020 AGENDA
10:00 AM
– 10:15 AM
Welcome
Oscar Puig, Ph.D.
Event Chair
Translational Medicine, Oncology Late Stage Development
Translational Medicine, Oncology Late Stage Development
Eli Lilly
Ronnye Schreiber
CEO
PlanetConnect
10:15 AM
– 11:00 AM
Keynote
KEYNOTE: Companion Diagnostics: Current Landscape and Future
Directions
Steve Anderson, Ph.D.
Chief Scientific Officer
Covance
11:00 AM
– 11:30 AM
BREAK and Meet your colleagues!
11:30 AM
– 12:30 PM
Track 1: Biomarkers for Neurological Disorders
New Frontiers in CNS Blood-based Biomarkers
Andreas Jeromin, Ph.D.
Chief Scientific Officer
Cohen Veterans Biosciences
Biomarkers for patient selection and monitoring drug treatments in
ALS clinical trials
Robert Bowser, Ph.D.
Chief Scientific Officer
Barrow Neurological Institute
12:30 PM
– 1:30 PM
LUNCH BREAK and Discussion Group
1:30 PM
– 3:00 PM
Track 2: Next Generation Biomarkers in Oncology
A Saliva-based ctDNA Diagnostic for Oral Cancer
Radhakrishna Bettadapura
Senior Director Business Development
Strand Life Science
Representative sampling to address tumor heterogeneity
Nelson Alexander,Ph.D.
Research Leader
Roche Sequencing Solutions
NGS-based approach Microsatellite Instability detection using
tumor only sample
Wei Ding, Ph.D.
Head of Bioinformatics
Admera Health
Chief Scientific Officer
Admera Health, China
3:00 PM
See you tomorrow at 10:00 AM EST
10:00 AM
– 11:15 AM
Track 3: Technology and Platforms
Enabling the Expansive Interrogation of a Tumor & Its
Microenvironment from a Single Sample for Translational Research
and Precision Medicine
Christelle Johnson. Ph.D.
Senior Field Applications Scientist
Personalis
Dawn McHugh
Senior Director, Strategic Business Development
Personalis
Signature Sponsor
Strategies for biomarker screening, identification, and validation
in early stage translational research projects into clinical
application
Jacques Corriveau
President & CEO
Ultivue
11:15 AM
– 12:15 PM
Track 4: Companion Diagnostics Development
Considerations for Development and Implementation of a CDx
Karen Richards, RAC
Senior Vice President, In Vitro Diagnostics and Quality
Precision for Medicine
Key Considerations for Late-Stage Diagnostic Development
Lloye Dillon, Ph.D.
Associate Director, Pharmacodiagnostics
Bristol-Myers Squibb
12:15 PM
– 1:00 PM
LUNCH BREAK and Discussion Group
1:00 PM
– 2:00 PM
Track 5: Pain Points and Barriers to Innovation
The evolving landscape of oncology clinical trials: clinician
perspectives on drivers and barriers to pharmaceutical innovation
Colin Enderlein
Project Leader
DeciBio
Update on the adoption and utilization of emerging precision
medicine tools and technologies in routine clinical care
Andrew Aijian, Ph.D.
Partner
DeciBio
2:00 PM
– 2:30 PM
Meet the Speaker – Discussion Group
3:00 PM
Thank you for coming!